The authors observed that a glioma tumor cell line that does not express HLA-G, when treated with the hypoxia-mimicking agent desferrioxamine (DFX), expressed high amounts of HLA-G mRNA and protein. The gene discussed is HLA-G; the disease is central nervous system cancer.